Max Healthcare Institute dividend and valuation
Valuation
Max Healthcare Institute paid ₹2.00 per share in dividends over the last 12 months (yield 0.2%). Last ex-dividend date: July 3, 2026. The P/E ratio is 67.0. The average price target of 27 analysts is ₹1,104.89.
Data as of November 21, 2026
Max Healthcare Institute compared with similar companies
Max Healthcare Institute's P/E (trailing 12 months): 67.0, +155% against the median of a group of 11 similar companies (26.2).
| Metric | Max Healthcare Institute | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 67.0 | 26.2 | 14.6 – 48.4 | High |
| Forward P/E | 41.3 | 20.1 | 11.5 – 31.0 | High |
| EV/EBITDA | 40.0 | 13.2 | 8.14 – 24.8 | High |
| Price/book | 8.14 | 3.84 | 2.91 – 5.52 | High |
| Price/sales | 10.1 | 1.81 | 0.69 – 4.16 | High |
| Gross margin | 63.1% | 35.5% | 25.3% – 44.9% | High |
| Operating margin | 21.4% | 15.2% | 10.5% – 19.3% | High |
| Net margin | 15.1% | 8.0% | 6.8% – 10.3% | High |
| ROE | 12.8% | 17.1% | 10.7% – 21.1% | Middle |
| Debt/equity | 0.33 | 0.79 | 0.53 – 1.43 | Low |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Max Healthcare Institute: valuation over time
On the latest fiscal year's earnings (2026), Max Healthcare Institute's P/E today is 73.2, in line with the median of its last 5 fiscal years (65.2; between 38.8 and 99.6 from 2022 to 2026). Relative to earnings, it costs about the same as in the past. The dividend yield (0.2%) is in line with the median of the last 4 fiscal years (0.2%).
| Fiscal year | Price at year end | Earnings per share | P/E | Dividend per share | Yield |
|---|---|---|---|---|---|
| Mar 2026 | ₹962.30 | ₹14.76 | 65.2 | ₹2.00 | 0.2% |
| Mar 2025 | ₹1,096.95 | ₹11.01 | 99.6 | ₹1.50 | 0.1% |
| Mar 2024 | ₹819.90 | ₹10.84 | 75.6 | ₹1.50 | 0.2% |
| Mar 2023 | ₹441.10 | ₹11.36 | 38.8 | ₹1.00 | 0.2% |
| Mar 2022 | ₹347.65 | ₹6.24 | 55.7 | — | — |
| Mar 2021 | ₹205.75 | -₹1.59 | — | — | — |
TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.
TickerLandia analysisHow it is calculated
Other metrics
Valuation multiples
- Market cap
- ₹921.84B
- Enterprise value
- ₹956.76B
- EV/revenue
- 10.5
Profitability and growth
- ROA
- 7.0%
- ROIC
- 8.5%
- Revenue growth (year over year)
- 20.3%
- Earnings growth (year over year)
- -15.5%
Financial health
- Total cash
- ₹5.71B
- Total debt
- ₹37.95B
- Current ratio
- 0.84
- Quick ratio
- 0.73
- Piotroski F-Score
- 6.00
Dividends
- Annual dividend per share
- ₹2.00
- Dividend yield
- 0.2%
- Payout ratio
- 14.2%
- Ex-dividend date
- July 3, 2026
Analysts and estimates
- Average price target
- ₹1,104.89
- Median price target
- ₹1,150.00
- High price target
- ₹1,300.00
- Low price target
- ₹825.00
- Analysts with a price target
- 27
- Consensus
- Buy
- Forward EPS
- ₹22.92
- EPS estimate, current year
- ₹18.46
Shares and trading
- Beta
- 0.18
- Average volume
- 2.86M
- Shares outstanding
- 973.33M
- Float
- 699.96M
- Institutional ownership
- 58.0%
- Insider ownership
- 28.1%
